Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectointercostal and ESP Block in Pediatric Cardiac Surgery
NCT05590026Phase 4Unknown
- Sponsor
- Cukurova University
- Start
- Oct 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Cukurova University. Primary endpoints: Face, Legs, Activity, Cry, Consolability at 24 hours and Postoperative morphine consumption at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05590026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590026.